BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 5, 2012

View Archived Issues

Stem cell gene therapy improves erectile dysfunction in rats

Read More

Novel HCV candidate identified by group in Taiwan

Read More

Roche Glycart patents novel IL-2 immunoconjugates

Read More

Russian group prepares new monoclonal antibodies

Read More

Plexxikon discloses novel protein kinase inhibitors

Read More

A novel pan-JAK inhibitor shows promise for adjuvant-induced arthritis

Read More

Indiana University researchers divulge new peptide phospholipid conjugates

Read More

Teduglutide receives European marketing authorization for short bowel syndrome

Read More

Novel antibacterial agents presented by Daiichi Sankyo

Read More

BioLineRx and Biokine Therapeutics enter licensing agreement for hematological cancers

Read More

Enrollment completed in phase III ATX-101 trial for submental fat

Read More

GlaxoSmithKline identifies novel DNA gyrase inhibitors for the treatment of tuberculosis

Read More

First patient enrolled in phase II AVP-923 trial in Alzheimer's disease

Read More

Sarepta Therapeutics receives U.S. government funding for Marburg virus therapy

Read More

Zalicus begins first of two phase IIa Z-160 studies in neuropathic pain

Read More

ImmusanT begins Nexvax-2 trials in celiac disease

Read More

AlloCure begins phase II study in acute kidney injury

Read More

BioSante Pharmaceuticals reports phase III safety data for LibiGel

Read More

Myrexis returns compounds to EpiCept

Read More

Relmada Therapeutics devises extended-release delivery systems for REL-1041

Read More

Baxter submits BLA to FDA seeking approval of hemophilia B drug

Read More

NIDA to fund phase II methamphetamine addiction trial of MN-166

Read More

GSK-961081 demonstrates efficacy as a bronchodilator in a phase II study

Read More

FDA approves Pfizer's bosutinib for CML

Read More

Medivir acquires preclinical antiviral programs from Novadex

Read More

New funding supports Cellerant's development of CLT-008

Read More

Dainippon Sumitomo Pharma seeks Chinese approval for amrubicin for SCLC

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 3, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • Art concept for medical research

    MicroRNAs in circulating extracellular vesicles as IPF biomarkers

    BioWorld Science
    MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing